A scientist using a pipette.

A Leader in Scientific Breakthroughs

BrightFocus Foundation is a premier private funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma.  We are currently managing a nearly $75+ million global portfolio of more than 280 scientific projects.

Recently Funded

Learn more about grants awarded in the most current fiscal year (nearly $25 million in funding for 95new awards in FY2022).

Culture of cortical neurons.

Nearly $14 million in funding for 55 new ADR awards in FY22.

A senior man having an eye exam.

Nearly $7 million in funding for 21 new MDR awards in FY22.

A close up of an eye.

Nearly $4 million in funding for 19 new NGR awards in FY22.

Latest News

Research News

In recognition of his critical discoveries in Alzheimer’s disease research, BrightFocus scientific alumnus Donald Weaver, MD, PhD, a clinical neurologist at the University of Toronto, has been awarded a prestigious silver-level Oskar Fischer Prize for introducing the unconventional hypothesis that Alzheimer’s disease is an autoimmune disorder.

Aug 05, 2022
Press Release

BrightFocus Foundation, a leading nonprofit funder of vision research, has announced a request for proposals for scientific projects supported through its National Glaucoma Research (NGR) program. The application deadline is October 25, 2022, for projects beginning in 2023.

Press Release

BrightFocus Foundation’s Alzheimer’s Disease Research program announced a request for scientific proposals for promising research on Alzheimer’s disease and related dementias. The application deadline is November 1, 2022, for projects beginning in 2023.